LEADER 01461nam  2200421   450 
001 9910714994903321
005 20221026081507.0
035   $a(CKB)2670000000429539
035   $a(NjHacI)992670000000429539
035   $a(OCoLC)818316810
035   $a(EXLCZ)992670000000429539
100   $a20221026d2012      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMultigene panels in prostate cancer risk assessment /$fJulian Little [and seven others]
210  1$aRockville, MD :$cAgency for Healthcare Research and Quality,$d[2012]
210  4$dİ2012
215   $a1 online resource (166 pages) $cillustrations
225 1 $aEvidence Reports/Technology Assessments ;$vIssue 209
300   $a"July 2012."
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vIssue 209.
606   $aProstate$xCancer$xResearch
615  0$aProstate$xCancer$xResearch.
676   $a616.994630072
700   $aLittle$b Julian$01354195
702   $aLittle$b Julian
712 02$aUnited States.$bAgency for Healthcare Research and Quality,
712 02$aMcMaster University.$bEvidence-based Practice Center.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910714994903321
996   $aMultigene panels in prostate cancer risk assessment$93309492
997   $aUNINA